Mixed Membranous Nephropathy Presenting as Severe Autoimmune Hemolytic Anemia (KIDNEY WEEK 2026) - Oct 2, 2026 - Abstract #FR-PO0691; Pres time: Oct 23, 2026; 10:00 AM - 12:00 PM; Location: Exhibit Hall A, Convention Center; "During initial management of AIHA, the patient was empirically initiated on high-dose prednisone and rituximab by Hematology. Our case highlights the limited efficacy of rituximab in this overlap. Cyclophosphamide is currently being trialed."
Anemia • Autoimmune Hemolytic Anemia • Glomerulonephritis • Immunology • Inflammatory Arthritis • Lupus • Lupus Nephritis • Nephrology • Renal Disease • Systemic Lupus Erythematosus • EXT1 • NELL1
|
|
Mohannad Abdeltawwab; Guido M. Capriles; Amit K. Rajput
|